- Home
- SURG vs PMVP Comparison
SURG vs PMVP Comparison
Compare SURG & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- PMVP
- Stock Information
- Founded
- SURG 2006
- PMVP 2013
- Country
- SURG United States
- PMVP United States
- Employees
- SURG N/A
- PMVP N/A
- Industry
- SURG Advertising
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- SURG Consumer Discretionary
- PMVP Health Care
- Exchange
- SURG Nasdaq
- PMVP Nasdaq
- Market Cap
- SURG 56.1M
- PMVP 62.3M
- IPO Year
- SURG N/A
- PMVP 2020
- Fundamental
- Price
- SURG $2.27
- PMVP $1.56
- Analyst Decision
- SURG Strong Buy
- PMVP Strong Buy
- Analyst Count
- SURG 1
- PMVP 1
- Target Price
- SURG $9.00
- PMVP $5.00
- AVG Volume (30 Days)
- SURG 166.5K
- PMVP 290.6K
- Earning Date
- SURG 08-13-2025
- PMVP 08-07-2025
- Dividend Yield
- SURG N/A
- PMVP N/A
- EPS Growth
- SURG N/A
- PMVP N/A
- EPS
- SURG N/A
- PMVP N/A
- Revenue
- SURG $36,461,935.00
- PMVP N/A
- Revenue This Year
- SURG $57.76
- PMVP N/A
- Revenue Next Year
- SURG $112.61
- PMVP N/A
- P/E Ratio
- SURG N/A
- PMVP N/A
- Revenue Growth
- SURG N/A
- PMVP N/A
- 52 Week Low
- SURG $1.05
- PMVP $0.81
- 52 Week High
- SURG $3.47
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- SURG 33.19
- PMVP 63.17
- Support Level
- SURG $2.81
- PMVP $1.42
- Resistance Level
- SURG $3.05
- PMVP $1.61
- Average True Range (ATR)
- SURG 0.24
- PMVP 0.09
- MACD
- SURG -0.07
- PMVP -0.00
- Stochastic Oscillator
- SURG 22.10
- PMVP 78.85
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.